• Je něco špatně v tomto záznamu ?

Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus

L. Eyer, M. Šmídková, R. Nencka, J. Neča, T. Kastl, M. Palus, E. De Clercq, D. Růžek,

. 2016 ; 133 (-) : 119-29. [pub] 20160728

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017127

Grantová podpora
NV16-34238A MZ0 CEP - Centrální evidence projektů

Tick-borne encephalitis (TBE) represents one of the most serious arboviral neuro-infections in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBE virus (TBEV) infection. Using two standardised in vitro assay systems, we evaluated a series of 29 nucleoside derivatives for their ability to inhibit TBEV replication in cell lines of neuronal as well as extraneural origin. The series of tested compounds included 2'-C- or 2'-O-methyl substituted nucleosides, 2'-C-fluoro-2'-C-methyl substituted nucleosides, 3'-O-methyl substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase modified nucleosides and neplanocins. Our data demonstrate a relatively stringent structure-activity relationship for modifications at the 2', 3', and 4' nucleoside positions. Whereas nucleoside derivatives with the methylation at the C2' position or azido modification at the C4'position exerted a strong TBEV inhibition activity (EC50 from 0.3 to 11.1 μM) and low cytotoxicity in vitro, substitutions of the O2' and O3' positions led to a complete loss of anti-TBEV activity (EC50 > 50 μM). Moreover, some structural modifications of the heterobase moiety resulted in a high increase of cytotoxicity in vitro. High antiviral activity and low cytotoxicity of C2' methylated or C4' azido substituted pharmacophores suggest that such compounds might represent promising candidates for further development of potential therapeutic agents in treating TBEV infection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017127
003      
CZ-PrNML
005      
20230808135447.0
007      
ta
008      
180515s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.antiviral.2016.07.018 $2 doi
035    __
$a (PubMed)27476046
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Eyer, Luděk $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic. $7 xx0098551
245    10
$a Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus / $c L. Eyer, M. Šmídková, R. Nencka, J. Neča, T. Kastl, M. Palus, E. De Clercq, D. Růžek,
520    9_
$a Tick-borne encephalitis (TBE) represents one of the most serious arboviral neuro-infections in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBE virus (TBEV) infection. Using two standardised in vitro assay systems, we evaluated a series of 29 nucleoside derivatives for their ability to inhibit TBEV replication in cell lines of neuronal as well as extraneural origin. The series of tested compounds included 2'-C- or 2'-O-methyl substituted nucleosides, 2'-C-fluoro-2'-C-methyl substituted nucleosides, 3'-O-methyl substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase modified nucleosides and neplanocins. Our data demonstrate a relatively stringent structure-activity relationship for modifications at the 2', 3', and 4' nucleoside positions. Whereas nucleoside derivatives with the methylation at the C2' position or azido modification at the C4'position exerted a strong TBEV inhibition activity (EC50 from 0.3 to 11.1 μM) and low cytotoxicity in vitro, substitutions of the O2' and O3' positions led to a complete loss of anti-TBEV activity (EC50 > 50 μM). Moreover, some structural modifications of the heterobase moiety resulted in a high increase of cytotoxicity in vitro. High antiviral activity and low cytotoxicity of C2' methylated or C4' azido substituted pharmacophores suggest that such compounds might represent promising candidates for further development of potential therapeutic agents in treating TBEV infection.
650    _2
$a zvířata $7 D000818
650    _2
$a antivirové látky $x chemie $x farmakologie $7 D000998
650    _2
$a buněčné linie $7 D002460
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a viry klíšťové encefalitidy $x účinky léků $7 D004669
650    _2
$a klíšťová encefalitida $x farmakoterapie $x virologie $7 D004675
650    _2
$a molekulární struktura $7 D015394
650    _2
$a nukleosidy $x chemie $x farmakologie $7 D009705
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a prasata $7 D013552
650    _2
$a replikace viru $x účinky léků $7 D014779
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šmídková, Markéta, $d 1974- $7 xx0226455 $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Fleming Sq. 2, CZ-16610 Prague, Czech Republic.
700    1_
$a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Fleming Sq. 2, CZ-16610 Prague, Czech Republic.
700    1_
$a Neča, Jiří $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
700    1_
$a Kastl, Tomáš $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
700    1_
$a Palus, Martin $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, and Faculty of Science, University of South Bohemia, Branišovská 31, CZ-37005 České Budějovice, Czech Republic.
700    1_
$a De Clercq, Erik $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
700    1_
$a Růžek, Daniel, $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, and Faculty of Science, University of South Bohemia, Branišovská 31, CZ-37005 České Budějovice, Czech Republic. Electronic address: ruzekd@paru.cas.cz. $d 1981- $7 stk2008441707
773    0_
$w MED00000480 $t Antiviral research $x 1872-9096 $g Roč. 133, č. - (2016), s. 119-29
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27476046 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20230808135444 $b ABA008
999    __
$a ok $b bmc $g 1300751 $s 1013967
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 133 $c - $d 119-29 $e 20160728 $i 1872-9096 $m Antiviral research $n Antiviral Res $x MED00000480
GRA    __
$a NV16-34238A $p MZ0
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...